The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Celldex; Celldex; Celldex; Celldex; Eisai; Eisai; Eisai; Eisai; Genentech; Genentech; Genentech; Genentech; Gritstone Bio; Gritstone Bio; Gritstone Bio; Gritstone Bio; Ipsen; Ipsen; Ipsen; Ipsen; IVT Medical; IVT Medical; IVT Medical; IVT Medical; Lexicon; Lexicon; Lexicon; Lexicon; Lilly; Lilly; Lilly; Lilly; Novartis; Novartis; Novartis; Novartis; Sanofi; Sanofi; Sanofi; Sanofi; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Research Funding - ASLAN Pharmaceuticals; ASLAN Pharmaceuticals; ASLAN Pharmaceuticals; ASLAN Pharmaceuticals; Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst)
 
Consulting or Advisory Role - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; Eisai; Eisai; Eisai; Eisai; Exelixis; Exelixis; Exelixis; Exelixis; Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; Genentech; Genentech; Genentech; Genentech; Ipsen; Ipsen; Ipsen; Ipsen
Speakers' Bureau - Amgen; Amgen; Amgen; Amgen; Eisai; Eisai; Eisai; Eisai; Exelixis; Exelixis; Exelixis; Exelixis; Ipsen; Ipsen; Ipsen; Ipsen; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical
Research Funding - AZD (Inst); AZD (Inst); AZD (Inst); AZD (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst)
Real-world treatment patterns and survival in patients (pts) with hepatocellular carcinoma in the United States.
 
Michael Morse
No Relationships to Disclose
 
Anne-Marie Meyer
Employment - Roche; Roche; Roche; Roche
 
Marcus Lawrance
Employment - GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech
Stock and Other Ownership Interests - GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech
 
Marta Pereira
Employment - Roche; Roche; Roche; Roche
Stock and Other Ownership Interests - Roche; Roche; Roche; Roche
 
Shivani K. Mhatre
Employment - Genentech; Genentech; Genentech; Genentech
 
Vincent Gaillard
Employment - Roche; Roche; Roche; Roche
Stock and Other Ownership Interests - Roche; Roche; Roche; Roche
Travel, Accommodations, Expenses - Roche; Roche; Roche; Roche
 
Farshid Dayyani
No Relationships to Disclose